Sensex 27975.86 517.22 1.88%
Nifty 8492.3 150.9 1.81%
Pfizer Inc is planning to acquire India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of $2 bn, according to reports.
Reports stated that the deal could be reached this quarter.
Agila makes cancer treatments and antibiotics.
India Infoline Research Team / 15:28, Mar 13, 2015
Markets are now reinforcing the perception of an early interest rate hike by US Federal Reserve, with consensus calling for the hike taking place in June, when compared with the prior expectations of a hike in September.